logo
Plus   Neg
Share
Email

Zimmer Biomet Guides FY20 In Line With Estimates - Quick Facts

While reporting financial results for the fourth quarter on Tuesday, Zimmer Biomet Holdings Inc. (ZBH) initiated its adjusted earnings and revenue growth outlook for the full-year 2020.

For fiscal 2020, the company now expects adjusted earnings in a range of $8.15 to $8.45 per share on projected revenue growth of 2.5 to 3.5 percent from last year on a reported and constant currency basis.

On average, analysts polled by Thomson Reuters expect the company to earn $8.29 per share on revenue growth of 2.50 percent to $8.16 billion for the year.

The Company also recently began a number of restructuring initiatives, including reorganizing business units to create greater strategic alignment, increased efficiency and improved resource allocation for accelerated growth.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Apotex Corp. recalled all lots of type 2 diabetes medication Metformin hydrochloride in the form of oral film-coated tablets for the potential presence of nitrosamine impurity, N-Nitrosodimethylamine (NDMA), above levels of the Acceptable Daily Intake Limit (ADI), the U.S. Food and Drug Administration or FDA said in a statement. Groupe Renault plans to cut about 14,600 jobs across the world and lower its production capacity. The plan includes almost 4,600 jobs reduction in France, through voluntary retirement and retraining. Amazon said it will convert 125,000 of the 175,000 temporary workers it hired in March amid the coronavirus pandemic, to permanent full-time employees in June. The e-commerce giant had hired the temporary employees in March to meet strong consumer demand amid the lockdown. The job openings were in Amazon's fulfillment centers and its delivery network.
Follow RTT